1)Teede H, et al : International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. Monash University, 2023 https://doi.org/10.26180/24003834.v1
2)Rodriguez Paris V, et al : The mechanism of androgen actions in PCOS etiology. Med Sci(Basel) 7 : 89, 2019
3)Zawadski JK, et al : Diagnostic criteria for polycystic ovary syndrome : towards a rational approach. Dunaif A, et al(eds) : Polycystic ovary syndrome. pp377-384, Blackwell Scientific, Boston, 1992
4)Azziz R, et al : Positions statement : criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An Androgen Excess Society guideline. J Clin Endocrinol Metab 91 : 4237-4245, 2006
5)本邦における多囊胞性卵巣症候群の診断基準の検証に関する小委員会 : 多囊胞性卵巣症候群に関する全国症例調査の結果と本邦における新しい診断基準(2024)について.https://www.jsog.or.jp/news/pdf/PCOS1_20231204.pdf
6)The Rotterdam ESHRE ASRM-sponsored PCOS Consensus Work shop Group : Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 : 19-25, 2004/Hum Reprod 19 : 41-47, 2004
7)National Institute of Health : Evidence-based Methodology Workshop on Polycystic Ovary Syndrome(PCOS). 2012. https://prevention.nih.gov/research-priorities/research-needs-and-gaps/pathways-prevention/evidence-based-methodology-workshop-polycystic-ovary-syndrome-pcos
8)Rosenfield RL, et al : The pathogenesis of polycystic ovary syndrome(PCOS) : the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37 : 467-520, 2016
9)Baba T, et al : Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro. Hum Reprod 32 : 2456-2464, 2017
10)Fujibe Y, et al : Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice. J Ovarian Res 12 : 31, 2019
11)Jonard S, et al : The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10 : 107-117, 2004
12)Sozen I, et al : Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstet Gynecol Surv 55 : 321-328, 2000
13)Dinicola S, et al : Inositols : from established knowledge to novel approaches. Int J Mol Sci 22 : 10575, 2021
14)Heimark D, et al : Decreased myo-inositol to chiro-inositol(M/C)ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J 61 : 111-117, 2014
15)Yamada C, et al : Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects. J Diabetes Investig 3 : 384-387, 2012
16)Niki H, et al : Improvement in diagnostic performance of the revised total testosterone measuring system in Japanese women with polycystic ovary syndrome. J Med Invest 61 : 65-71, 2014
17)尋常性痤瘡・酒皶治療ガイドライン策定委員会 : 尋常性痤瘡・酒皶治療ガイドライン2023.日皮会誌 133 : 407-450, 2023